Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

US Stocks Higher; Schlumberger Earnings Beat Estimates

Published 19/01/2024, 14:53
© Reuters.  US Stocks Higher; Schlumberger Earnings Beat Estimates

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday.

Following the market opening Friday, the Dow traded up 0.18% to 37,536.76 while the NASDAQ rose 0.38% to 15,113.04. The S&P 500 also rose, gaining, 0.19% to 4,790.00.

Check This Out: Jim Cramer Predicts A 'Terrific Year' For This Manufacturer, And As For U-Haul? 'I'm Fine With It'

Leading and Lagging Sectors

Information technology shares rose by 0.6% on Friday.

In trading on Friday, utilities shares fell by 0.3%.

Top Headline

Schlumberger Limited (NYSE: SLB) posted better-than-expected earnings for its fourth quarter.

SLB posted adjusted earnings of 86 cents per share, beating market estimates of 84 cents per share. The company’s quarterly sales came in at $8.99 billion versus expectations of $8.96 billion.

Equities Trading UP

Kaman Corporation (NASDAQ: KAMN) shares shot up 101% to $45.10 after the company announced it will be acquired by Arcline for $1.8 billion.

Shares of Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) got a boost, surging 38% to $0.2800. Processa Pharmaceuticals announced plans to expand the development of next generation capecitabine (NGC-Cap) into advanced or metastatic breast cancer beginning with next Phase 2 trial in breast cancer.

Tricon Residential Inc. (NYSE: TCN) shares were also up, gaining 28% to $11.05 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Equities Trading DOWN

C3is Inc. (NASDAQ: CISS) shares dropped 65% to $0.1310 as the company announced pricing of $7.0 million upsized underwritten public offering.

Shares of Accelerate Diagnostics, Inc. (NASDAQ: AXDX) were down 38% to $0.9901 after the company reported pricing of approximately $15 million public offering and private placement.

iRobot Corporation (NASDAQ: IRBT) was down, falling 29% to $16.74 following a report suggesting the EU plans to block Amazon's acquisition of the company.

Also Check This Out: Top 3 Financial Stocks That May Implode In Q1

Commodities

In commodity news, oil traded up 0.4% to $74.35 while gold traded up 0.5% at $2,032.30.

Silver traded down 0.3% to $22.74 on Friday while copper rose 0.6% to $3.7670.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.2%, London’s FTSE 100 rose 0.2% while Spain’s IBEX 35 Index fell 0.1% The German DAX fell 0.2% French CAC 40 fell 0.143% while Italy’s FTSE MIB Index fell 0.1%.

Producer prices in Germany declined 8.6% year-over-year in December compared to a 7.9% fall in the previous month. Retail sales in the UK fell by 3.2% in December compared to a revised 1.4% rise in the prior month.

Asia Pacific Markets

Asian markets closed mixed on Friday, with Japan’s Nikkei 225 gaining 1.40%, Hong Kong’s Hang Seng Index falling 0.54% and China’s Shanghai Composite Index declining 0.47%. India’s S&P BSE Sensex, meanwhile, rose 0.70%.

Foreign direct investment into China declined by 8% year-over-year to CNY 1.13 trillion ($157.1 billion) in 2023. The business confidence indicator in Hong Kong declined to +1 in the first quarter versus a reading of +8 in the prior three-month period. The annual inflation rate in Japan slowed to 2.6% in December from 2.8% in the earlier month, recording the lowest reading since July 2022.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Economics

Data on existing home sales will be released at 10:00 a.m. ET.

Now Read This: How To Earn $500 A Month From AT&T Stock Ahead Of Q4 Print

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.